Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion type Assertion NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_head.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion description "[This review discusses potentials of using recombinant ADAMTS-13 and VWF-blocking agents as therapeutics for TTP and other acquired ADAMTS-13 deficiencies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_provenance.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion evidence source_evidence_literature NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_provenance.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion SIO_000772 22022775 NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_provenance.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion wasDerivedFrom befree-2016 NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_provenance.
- NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_assertion wasGeneratedBy ECO_0000203 NP933240.RAVLJ-mhPXHInflq5mY2Pn6GT5qI-utEf5JIozP986nK8130_provenance.